Upgrade to SI Premium - Free Trial

Evercore ISI Downgrades Teva Pharma (TEVA) to In Line

August 7, 2019 10:03 AM
Evercore ISI analyst Umer Raffat downgraded Teva Pharma (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles